Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

155.75 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 35,310
Open 155.75
Bid (Size) 155.16 (1)
Ask (Size) 155.78 (1)
Prev. Close 155.75
Today's Range 155.75 - 155.75
52wk Range 150.11 - 181.04
Shares Outstanding 2,628,679,824
Dividend Yield 2.59%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Could Kenvue Follow in the Footsteps of Johnson & Johnson and Become a Top Dividend Stock?
Kenvue says rewarding shareholders is an important part of its strategy. 
Via The Motley Fool
Is Kenvue Stock Too Pricey to Buy?
Its valuation depends on its brands being highly valuable indefinitely. 
Via The Motley Fool

Performance

YTD
-12.59%
-12.59%
1 Month
-2.95%
-2.95%
3 Month
-4.65%
-4.65%
6 Month
-0.70%
-0.70%
1 Year
-4.56%
-4.56%

More News

Read More
3 Magnificent Dividend Stocks to Buy in October
Via The Motley Fool
Recession-Proof Royals: 3 Stocks That Thrive in Tough Economic Times
Via InvestorPlace
Don’t Miss Out: 3 Dividend Stocks to Buy on EVERY. SINGLE. DIP.
Via InvestorPlace
These 7 Dividend Stocks Pay $98 Billion Annually, Combined, to Their Shareholders
Via The Motley Fool
Looking At Johnson & Johnson's Recent Unusual Options Activity
Via Benzinga
(JNJ) - Analyzing Johnson & Johnson's Short Interest
Via Benzinga
Johnson & Johnson Unusual Options Activity
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Pharma Giants Shift Stance, Embrace Medicare Negotiations Amid Rising Drug Costs
Via Benzinga
What's Going On Pfizer's Subsidiary Biohaven Stock?
Via Benzinga
Why Immunovant Stock Is Bolting Higher Today
Via The Motley Fool
Biden's Urgent Action Against Antibiotic-Resistant Bacteria - Allocates $100M to Battle Deadly Superbugs
Via Benzinga
3 Things About Johnson & Johnson That Smart Investors Know
Via The Motley Fool
2 Monster Stocks to Buy Without Any Hesitation
Via The Motley Fool
3 Blue Chip Safe Havens to Shield Your Portfolio
Via MarketBeat
Topics ETFs Economy
Exposures Economy Interest Rates
3 Reasons SharkNinja Is Swimming Toward New Highs
Via MarketBeat
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
2 Incredibly Cheap Dividend Stocks to Buy Now
Via The Motley Fool
Flee to Healthcare Stocks if Recession Rears its Head?
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
Buying These 2 Stocks Is a Good Way to Hedge Against a Market Crash
Via The Motley Fool
3 No-Brainer Stocks to Buy With $500 Right Now
Via The Motley Fool
7 Safe and Steady Dividend Stocks to Buy for Volatile Time
Via InvestorPlace
The Breakthrough Therapy Aiming To Solve The World’s Mental Health Crisis
Via FinancialNewsMedia
Topics Economy
Exposures Economy Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.